Evidence map›Paper›PMID 9343416›Full record

ArticleMolecular and cellular biology1997

c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition.

J Bash, W X Zong, C Gélinas

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 106 citations in OpenAlex.

  1. Autonomous Oscillations of NF-κB.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Role of Hypoxia in the Control of the Cell Cycle.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. p65 Negatively regulates transcription of the cyclin E gene.The Journal of biological chemistry · 2010
    Article
  19. Article
  20. NF-kappaB and cancer: how intimate is this relationship.Molecular and cellular biochemistry · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

J BashCenter for Advanced Biotechnology and Medicine, and Graduate Program in Microbiology and Molecular Genetics, Rutgers University, Piscataway, New Jersey 08854, USA.
W X Zong
C Gélinas
Environmental and Occupational Health Sciences Institute · USRutgers Cancer Institute of New JerseyRutgers, The State University of New Jersey · US

Funding

TRANS-ACTING FUNCTION OF THE V- AND C-REL ONCOPROTEINSR01CA054999 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI GELINAS, CELINE · 1996 to 2005
$1.6M
TRANS-ACTING FUNCTION OF THE V- AND C-REL ONCOPROTEINSR29CA054999 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI GELINAS, CELINE · 1991 to 1995
–
NCI NIH HHS CA54999
6 · The paper itself

Abstract

A tetracycline-regulated system was used to characterize the effects of c-Rel on cell proliferation. The expression of c-Rel in HeLa cells led to growth arrest at the G1/S-phase transition, which correlated with its nuclear localization and the induction of endogenous IkappaB alpha expression. These changes were accompanied by a decrease in E2F DNA binding and the accumulation of the hypophosphorylated form of Rb. In vitro kinase assays showed a reduction in Cdk2 kinase activity that correlated with elevated levels of p21WAF1 Cdk inhibitor and p53 tumor suppressor protein. While the steady-state levels of WAF1 transcripts were increased, pulse-chase analysis revealed a sharp increase in p53 protein stability. Importantly, the deletion of the C-terminal transactivation domains of c-Rel abolished these effects. Together, these studies demonstrate that c-Rel can affect cell cycle control and suggest the involvement of the p21WAF1 and p53 cell cycle regulators.

Indexed as

Carrier ProteinsCDC2-CDC28 KinasesCell Cycle ProteinsI-kappa B ProteinsAnimalsApoptosisCell CompartmentationCell CycleCell DivisionCell NucleusChickensCyclin-Dependent Kinase 2Cyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent KinasesCyclinsDNA-Binding ProteinsCarrier ProteinsCDC2-CDC28 KinasesCDK2 protein, humanCDKN1A protein, humanCell Cycle ProteinsCyclin-Dependent Kinase 2Cyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent KinasesCyclinsDNA-Binding ProteinsE2F Transcription FactorsI-kappa B ProteinsNF-KappaB Inhibitor alphaNFKBIA protein, humanProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-relRecombinant ProteinsRetinoblastoma-Binding Protein 1Retinoblastoma ProteinTetracyclineTranscription Factor DP1Transcription FactorsTumor Suppressor Protein p53

Identifiers

PMID9343416
PMCPMC232506
OpenAlexW2149640683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.